申请人:CHEMOCENTRYX, INC.
公开号:US20170283446A1
公开(公告)日:2017-10-05
Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):
including stereoisomers and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
and R
3
are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.